The reduced cytotoxicity of NK cells as reported in COVID-19 patients is often concluded from decreased levels of perforin and granzymes or from decreased degranulation as analysed by CD107a expression after stimulation with tumour target cells (19, 28–30). The gene discussed is PRF1; the disease is COVID-19.